Medivation Prostate Therapeutics, Inc. is a biotechnology company based in San Fernando, California, specializing in the development of innovative therapies for prostate cancer. The organization focuses on advancing treatments that target the underlying mechanisms of cancer progression, aiming to improve patient outcomes through precision medicine. With a commitment to research and development, Medivation is dedicated to addressing unmet medical needs in oncology, particularly in the realm of prostate cancer therapeutics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#4 in San Fernando, CA

#6,061 in California

#25,557 in US

#48,163 in the World

San Fernando, CA, United States of America

Medivation Prostate Therapeutics, Inc.

Forward Citations = 19

28 inventors:

Amy Christian Peterson (3 out of 3 patents)

Hirdesh Uppal (3 out of 3 patents)

Sanjay Konagurthu (3 out of 7 patents)

4. Toshiro Sakai (3 out of 8 patents)

5. Koji Nishimura (3 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medivation Prostate Therapeutics, Inc.. Retrieved from https://idiyas.com/company/medivation-prostate-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]